Spermidine and spermine in elderly patients with coronary artery disease: a cross-sectional study of dietary intake and plasma and skeletal muscle concentrations

BACKGROUND AND AIMS: Spermidine, a polyamine abundant in plant-based and fermented foods, has been associated with reduced cardiovascular and all-cause mortality. However, whether dietary spermidine intake is reflected in circulating and skeletal muscle concentrations remains unclear, and tissue data are scarce. We therefore investigated the associations between dietary spermidine intake and spermidine concentrations in plasma and skeletal muscle in elderly patients with coronary artery disease. METHODS: We examined dietary spermidine and spermine intake using a food frequency questionnaire, and plasma and skeletal muscle concentrations by targeted LC-MS/MS. Associations between intake, plasma and skeletal muscle concentrations were assessed using multivariable linear regression models adjusted for age, sex, body mass index, educational level, total daily energy intake, serum creatinine, medical treatment and comorbidities. RESULTS: A total of 192 patients with coronary artery disease were included (age 72 years [68-76] and 80% male). Median dietary spermidine intake was 11.5 mg/day [9.5-14.3] (n = 184). Median spermidine concentrations were 21.0 ng/mL [16.2-27.1] in plasma (n = 188) and 7120 ng/g [6200-8500] in skeletal muscle (n = 101). Higher dietary spermidine intake was modestly associated with higher plasma spermidine concentrations, corresponding to an 18% higher plasma concentration per doubling of intake in the unadjusted model (p = 0.02). The association remained robust after adjustment for covariates (p < 0.05). Skeletal muscle spermidine concentrations were not associated with intake or plasma concentrations (p > 0.05). Skeletal muscle contained markedly higher polyamine concentrations than plasma, and skeletal muscle spermine exceeded spermidine 6.7-fold. Women exhibited higher energy-adjusted spermidine intake (p = 0.02) and higher skeletal muscle spermidine concentrations than men (p < 0.01). Participants with higher educational attainment had higher dietary spermidine intake and plasma spermidine concentrations (p < 0.05). CONCLUSIONS: These findings suggest that plasma spermidine reflects habitual dietary exposure to a limited extent, whereas skeletal muscle polyamine pools appear to be maintained by strong intracellular regulation. Potential sex-related differences in polyamine metabolism or tissue distribution warrant further investigation. Randomised controlled trials are required to establish causality and determine clinical relevance. TRIAL REGISTRATION: NCT06186102, registered at ClinicalTrials.gov on 7 December 2023 by the authors. TRIAL PROTOCOL: POLYCAD trial protocol, Trials, 2025.

Authors

Institutions

Publication Details

Journal
Clinical Nutrition
Published
2026-04-03
DOI
https://doi.org/10.1016/j.clnu.2026.106651
Primary Topic
Polyamine Metabolism and Applications
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spermidine and spermine in elderly patients with coronary artery disease: a cross-sectional study of dietary intake and plasma and skeletal muscle concentrations

Mogens Johannsen, Andreas Bugge Tinggaard, Henrik Wiggers, Christian Velling Thorup et al.
Clinical Nutrition
Polyamine Metabolism and Applications
article

Spermidine and spermine in elderly patients with coronary artery disease: a cross-sectional study of dietary intake and plasma and skeletal muscle concentrations

Mogens Johannsen, Andreas Bugge Tinggaard, Henrik Wiggers, Christian Velling Thorup, Christian Lodberg Hvas, Jakob Wang, Niels Jessen, Jean Farup, Charlotte Lock Rud, Thomas H. Jensen, Chris N.A. Jeppesen, Jakob Hansen
article en

Abstract

BACKGROUND AND AIMS: Spermidine, a polyamine abundant in plant-based and fermented foods, has been associated with reduced cardiovascular and all-cause mortality. However, whether dietary spermidine intake is reflected in circulating and skeletal muscle concentrations remains unclear, and tissue data are scarce. We therefore investigated the associations between dietary spermidine intake and spermidine concentrations in plasma and skeletal muscle in elderly patients with coronary artery disease. METHODS: We examined dietary spermidine and spermine intake using a food frequency questionnaire, and plasma and skeletal muscle concentrations by targeted LC-MS/MS. Associations between intake, plasma and skeletal muscle concentrations were assessed using multivariable linear regression models adjusted for age, sex, body mass index, educational level, total daily energy intake, serum creatinine, medical treatment and comorbidities. RESULTS: A total of 192 patients with coronary artery disease were included (age 72 years [68-76] and 80% male). Median dietary spermidine intake was 11.5 mg/day [9.5-14.3] (n = 184). Median spermidine concentrations were 21.0 ng/mL [16.2-27.1] in plasma (n = 188) and 7120 ng/g [6200-8500] in skeletal muscle (n = 101). Higher dietary spermidine intake was modestly associated with higher plasma spermidine concentrations, corresponding to an 18% higher plasma concentration per doubling of intake in the unadjusted model (p = 0.02). The association remained robust after adjustment for covariates (p < 0.05). Skeletal muscle spermidine concentrations were not associated with intake or plasma concentrations (p > 0.05). Skeletal muscle contained markedly higher polyamine concentrations than plasma, and skeletal muscle spermine exceeded spermidine 6.7-fold. Women exhibited higher energy-adjusted spermidine intake (p = 0.02) and higher skeletal muscle spermidine concentrations than men (p < 0.01). Participants with higher educational attainment had higher dietary spermidine intake and plasma spermidine concentrations (p < 0.05). CONCLUSIONS: These findings suggest that plasma spermidine reflects habitual dietary exposure to a limited extent, whereas skeletal muscle polyamine pools appear to be maintained by strong intracellular regulation. Potential sex-related differences in polyamine metabolism or tissue distribution warrant further investigation. Randomised controlled trials are required to establish causality and determine clinical relevance. TRIAL REGISTRATION: NCT06186102, registered at ClinicalTrials.gov on 7 December 2023 by the authors. TRIAL PROTOCOL: POLYCAD trial protocol, Trials, 2025.

Clinical NutritionVol. 61
Aarhus University (DK), Aarhus University Hospital (DK)
Danish Diabetes Academy, Steno Diabetes Center Aarhus, Danish Cardiovascular Academy
Zero hunger
Openalex Percentile: Top 35%
Polyamine Metabolism and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.